Claire J Hoogendoorn1, Juan F Roy2, Jeffrey S Gonzalez2,3. 1. Ferkauf Graduate School of Psychology, Yeshiva University, 1165 Morris Park Avenue, Rousso Building, Bronx, NY, 10461, USA. Claire.hoogendoorn@yu.edu. 2. Ferkauf Graduate School of Psychology, Yeshiva University, 1165 Morris Park Avenue, Rousso Building, Bronx, NY, 10461, USA. 3. Department of Medicine (Endocrinology), Albert Einstein College of Medicine, Bronx, NY, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to provide an overview of shared dysregulation of the hypothalamic-pituitary-adrenal (HPA) and brain-gut-microbiome (BGM) axes associated with depression and type 2 diabetes (T2D). Clinical implications and future research are also discussed. RECENT FINDINGS: Both depression and T2D are associated with dysregulation of the HPA and BGM axes. These pathways regulate immune function, glucose metabolism, and sleep, which are altered in both illnesses. Dysregulation of homeostatic brain-body pathways may be positively influenced through different therapeutic actions, including psychotherapy, healthy eating, physical activity, sleep promotion, and certain anti-inflammatory or antidepressant medications. While the causal nature of the relationship between depression and T2D remains unclear, these conditions share dysregulation of homeostatic brain-body pathways that are central to mental and physical health. Better understanding of this dysregulation may provide opportunities for interventions that could benefit both conditions. Future research should examine the additive burden of depression and T2D on HPA and BGM dysregulation and better differentiate depression from emotional distress.
PURPOSE OF REVIEW: The purpose of this review is to provide an overview of shared dysregulation of the hypothalamic-pituitary-adrenal (HPA) and brain-gut-microbiome (BGM) axes associated with depression and type 2 diabetes (T2D). Clinical implications and future research are also discussed. RECENT FINDINGS: Both depression and T2D are associated with dysregulation of the HPA and BGM axes. These pathways regulate immune function, glucose metabolism, and sleep, which are altered in both illnesses. Dysregulation of homeostatic brain-body pathways may be positively influenced through different therapeutic actions, including psychotherapy, healthy eating, physical activity, sleep promotion, and certain anti-inflammatory or antidepressant medications. While the causal nature of the relationship between depression and T2D remains unclear, these conditions share dysregulation of homeostatic brain-body pathways that are central to mental and physical health. Better understanding of this dysregulation may provide opportunities for interventions that could benefit both conditions. Future research should examine the additive burden of depression and T2D on HPA and BGM dysregulation and better differentiate depression from emotional distress.
Authors: M F Dallman; A M Strack; S F Akana; M J Bradbury; E S Hanson; K A Scribner; M Smith Journal: Front Neuroendocrinol Date: 1993-10 Impact factor: 8.606
Authors: Jeffrey S Gonzalez; Mark Peyrot; Lauren A McCarl; Erin Marie Collins; Luis Serpa; Matthew J Mimiaga; Steven A Safren Journal: Diabetes Care Date: 2008-12 Impact factor: 17.152
Authors: Elizabeth M Scott; Joanne S Carpenter; Frank Iorfino; Shane P M Cross; Daniel F Hermens; Jeanne Gehue; Chloe Wilson; Django White; Sharon L Naismith; Adam J Guastella; Ian B Hickie Journal: BMJ Open Date: 2019-05-27 Impact factor: 2.692
Authors: Juan Francisco Roy; María Luisa Lozano Del Hoyo; Fernando Urcola-Pardo; Alicia Monreal-Bartolomé; Diana Cecilia Gracia Ruiz; María Mercedes Gómez Borao; Ana Belén Artigas Alcázar; José Pedro Martínez Casbas; Alexandra Aceituno Casas; María Teresa Andaluz Funcia; Javier García-Campayo; María Teresa Fernández Rodrigo Journal: Sci Rep Date: 2021-04-26 Impact factor: 4.379
Authors: Charlotte Steenblock; Peter E H Schwarz; Nikolaos Perakakis; Naime Brajshori; Petrit Beqiri; Stefan R Bornstein Journal: Discov Ment Health Date: 2022-03-01